Which Is the Best GLP-1 for Weight Loss?

Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Compare the numbers: What GLP-1 programs actually cost per month →

GLP-1 receptor agonists have reshaped weight loss treatment, with semaglutide showing average weight reductions of 15% and tirzepatide reaching up to 22% in clinical trials. The question isn't which GLP-1 is universally "best"—it's which one aligns with your unique metabolic profile. PlexusDx delivers personalized GLP-1 therapy across all 50 states without insurance requirements, at $189/mo month-to-month, or from $149/mo on the 6-month plan.

How Semaglutide and Tirzepatide Work for Weight Loss

Semaglutide activates GLP-1 receptors in the brain and pancreas, slowing gastric emptying and increasing feelings of fullness after smaller meals. This single-pathway mechanism makes semaglutide predictable and well-tolerated for many patients beginning GLP-1 therapy. Clinical data shows consistent weight loss in the 10–15% range over 68 weeks of treatment.

Tirzepatide activates both GLP-1 and GIP receptors, creating a dual-hormone effect that enhances insulin sensitivity and appetite suppression simultaneously. The dual-pathway approach often produces stronger results—studies document weight losses of 20–22% at the highest doses. For patients whose bodies respond better to multi-target signaling, tirzepatide may accelerate progress toward weight loss goals.

Semaglutide Injection vs. Oral Options: What the Evidence Shows

Injected semaglutide delivers medication directly into subcutaneous tissue, bypassing the digestive system and achieving higher bioavailability than oral formulations. Weekly injections maintain steady GLP-1 receptor activation, which translates to more consistent appetite suppression and weight loss week over week. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan, making weekly dosing accessible without flat per-compound pricing increases.

Oral semaglutide requires absorption through the stomach lining and must be taken on an empty stomach with specific timing protocols. While oral formulations offer convenience for needle-averse patients, absorption variability can result in less predictable weight loss outcomes. PlexusDx offers both injection and oral semaglutide, allowing you to choose based on preference and tolerability.

Genetic Testing Reveals Your Best GLP-1 Match

Your genes influence how efficiently your body responds to GLP-1 and GIP signaling. The GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 variants affect appetite regulation, metabolic rate, and medication sensitivity. PlexusDx Precision Peptide Genetic Test maps 14 pathways and 49 peptides, providing 150+ personalized insights that guide selection between semaglutide, tirzepatide, or dual-compound formulas.

Patients with favorable GLP1R variants often see robust weight loss with semaglutide alone, while those with specific GIPR predispositions may experience superior results from tirzepatide's dual mechanism. The genetic test ($298) removes guesswork, allowing PlexusDx to recommend the therapy most aligned with your molecular metabolism rather than trial-and-error dosing.

Cost Comparison: Semaglutide, Tirzepatide, and Combination Therapy

PlexusDx semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) across all commitment tiers—your dose may increase, but your price remains flat. Tirzepatide injection is $289/mo month-to-month, or from $249/mo on the 6-month plan, and GLP-Squared dual-compound injection (semaglutide plus tirzepatide) is $289 monthly month-to-month. All medications are prepared by licensed 503A compounding pharmacies, are available in all 50 states without insurance, and qualify for HSA/FSA accounts.

Oral formulations carry higher monthly costs due to absorption challenges requiring larger effective doses: oral semaglutide at $289/mo (or $249/mo on the 6-month plan) and oral tirzepatide at $349/mo (or $279/mo on the 6-month plan). Patients seeking maximum convenience with injection efficacy choose PlexusDx injections, while those prioritizing needle-free administration opt for oral therapy. Neither pricing tier nor medication choice requires membership fees or insurance approval.

Who Sees the Best Results: Personalized Factors Beyond Price

Weight loss success depends on baseline BMI, metabolic health, adherence, and lifestyle integration rather than medication name alone. Patients with BMI >35 and metabolic syndrome often experience faster weight loss with tirzepatide's dual mechanism, while those with BMI 27–32 frequently achieve goals with semaglutide's simpler pathway. PlexusDx clinical support guides dose escalation and medication switches based on monthly progress tracking.

Genetic testing through PlexusDx Precision Peptide Genetic Test reveals whether your body favors GLP-1-dominant signaling or responds better to GIP co-activation, eliminating months of guesswork. Patients with high FTO rs9939609 risk alleles benefit from more aggressive appetite suppression—tirzepatide's mechanism—while those with favorable GLP1R variants achieve results with semaglutide's focused approach. Personalization, not brand names, determines success.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is semaglutide or tirzepatide better for my weight loss?

Neither is universally "better"—it depends on your genetics, metabolism, and BMI. Semaglutide works well for most patients and costs less ($189/mo injection); tirzepatide produces stronger results (20%+ weight loss) but costs more ($289/mo injection). PlexusDx Precision Peptide Genetic Test ($298) describes the pathway-level variants involved.

How much weight can I lose with semaglutide injections?

Clinical trials show average weight loss of 10–15% over 68 weeks with semaglutide injections. Individual results range from 5–20% depending on baseline weight, diet adherence, and genetic predisposition. PlexusDx patients track progress monthly and adjust doses based on response; your price stays flat at $189/month regardless of dose level.

Can I switch from semaglutide to tirzepatide if I'm not seeing results?

Yes. PlexusDx clinical support monitors your progress and can recommend a switch to tirzepatide ($289/mo injection) or GLP-Squared dual-compound ($289/mo injection) if semaglutide results plateau after 12–16 weeks. Medication changes are guided by clinical response and genetic insights from your Precision Peptide Genetic Test.

Are compounded GLP-1 injections from PlexusDx as safe as brand-name medications?

Yes. PlexusDx sources all medications from licensed 503A compounding pharmacies—the highest regulatory standard for pharmaceutical preparation. Compounded semaglutide and tirzepatide contain identical active ingredients to brand medications and undergo the same quality controls. All PlexusDx patients receive clinical support, dosing guidance, and side-effect monitoring.

What does the PlexusDx Precision Peptide Genetic Test measure?

The test identifies genetic variants in GIPR, FTO, and MC4R, and 10 other appetite-metabolism pathways affecting 49 peptides. Results show whether you're a responder to GLP-1-only therapy (semaglutide) or benefit from dual GLP-1/GIP activation (tirzepatide). At $298, the test personalizes your entire treatment plan and increases success rates.

Related Reading

• Glp 1 For Weight Loss 2
• Glp 1 Weight Loss Before And After
• Glp 1 Dosage For Weight Loss
• Glp 1 Receptor Agonist For Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.